High blood pressure: open trials in Serbia

• NCT07064473

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Clinical Hospital Center Dr. Dragisa Misovic, Belgrade · University Clinical Center of Serbia, Belgrade · Clinical. Hospital Center Zvezdara, Belgrade · Institute of Cardiovascular Diseases of Vojvodine, Kamenitz · University Clinical Center of Kragujevac, Kragujevac · Institute for Treatment and Rehabilitation, Niska Banja, Niška Banja · General Hospital Pancevo, Pančevo

  Registry updated 2026-10-28

• NCT07473700

  Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  Trial Treatment · Phase 2 · Tectonic Operating Company, Inc.

  Belgrade,, Belgrade · Sremska Kamenica, Kamenitz · Niš, Niš

  Registry updated 2026-10-27

• NCT07179380

  Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Trial Treatment · Phase 3 · Insmed Incorporated

  SRB001, Belgrade · SRB004, Belgrade · SRB002, Kamenitz · SRB003, Kragujevac

  Registry updated 2026-10-26

• NCT07181109

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Belgrade · Ćuprija · Kamenitz · Kragujevac · Leskovac · Niš · Niška Banja · Zaječar · Zrenjanin

  Registry updated 2026-10-15

• NCT06274801

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Trial Treatment · Phase 3 · Gossamer Bio USA, Inc.

  University Clinical Centre of Serbia, Cardiology Clinic, Belgrade

  Registry updated 2026-10-13

• NCT03683186

  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Trial Treatment · Phase 3 · United Therapeutics

  Clinical Center of Serbia, Koste Todorovica 8, Belgrade · Clinical Center Zemun. Clinic for internal medicine, Department of Cardiology, Belgrade · Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Kamenitz

  Registry updated 2026-10-06

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Belgrade · Kamenitz · Kragujevac · Niš · Novi Sad

  Registry updated 2026-09-25

• NCT06649110

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Belgrade · Kamenitz · Niš

  Registry updated 2026-07-21

• NCT06775028

  Integrated Approach in Frail Older People with Atrial Fibrillation

  Trial Treatment · Heart Care Foundation

  University Clinical Centre of Serbia-Department for invasive electrophysiology, Belgrade · KBC Bezanijska Kosa-Cardiology Department, Belgrade · KBC Zemun-Cardiology Department, Belgrade · University Clinical Centre of Serbia-Emergency centre, Belgrade · Institute for Cardiovascular Diseases Dedinje-Pacemaker and electrophysiology department, Belgrade · University Clinical Centre of Serbia-Department for cardiac arrhythmias, Belgrade · University Clinical Centre of Kragujevac-Cardiology Department, Kragujevac · University Clinical Centre of Nis-Cardiology Department, Niš

  Registry updated 2025-01-14

All High blood pressure trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error